Pregnancy loss, recurrent, susceptibility

This phase 3 trial tests whether adding enoxaparin, a blood thinner, to standard progesterone treatment increases the chance of a live birth in women who have had two or more unexplained miscarriages. Participants receive either progesterone alone or progesterone plus daily enoxa…

This study tests whether adding letrozole, a drug commonly used for breast cancer, to the standard medication misoprostol can improve the complete termination of second-trimester pregnancies (14-20 weeks). The trial will compare the combination against misoprostol alone in 80 wom…

This study compares a new method that combines a non-invasive genetic test (NICS) with artificial intelligence (AI) against the standard way of picking embryos by looks alone. It includes 520 women aged 35-43 or with a history of recurrent miscarriage who are doing IVF. The goal …

This study looks at why some women have abortions later in pregnancy (14-16 weeks) at Avignon Hospital in France. Researchers want to understand the personal, social, and healthcare barriers these women face. By interviewing 30 women, they hope to find ways to improve access to c…

This study looks at whether one session of magnetic brain stimulation can temporarily change how the heart and brain communicate in women who have had multiple pregnancy losses and are overweight. Sixty women will receive either real or fake stimulation while their heart activity…

This study will test whether structured educational sessions can improve how maternity nurses care for patients experiencing abortion. Sixty nurses will attend training covering lectures, demonstrations, and discussions. Researchers will observe their practices before and after t…

This study looks at 100 women undergoing fertility treatment to understand why some experience repeated implantation failure or pregnancy loss. Researchers will compare immune cells and microbes in the uterus of affected women versus those without such history. The goal is to fin…